GHRL and metabolic dysfunction-associated steatotic liver disease: Indeed, elevated circulating ghrelin levels have been associated with more severe MASLD phenotypes, suggesting that its beneficial effects may be context-dependent and ultimately insufficient to counteract disease progression.